PEGBING Trademark

Trademark Overview


On Thursday, December 16, 2021, a trademark application was filed for PEGBING with the United States Patent and Trademark Office. The USPTO has given the PEGBING trademark a serial number of 97175380. The federal status of this trademark filing is REGISTERED as of Tuesday, December 3, 2024. This trademark is owned by XIAMEN AMOYTOP BIOTECH CO., LTD.. The PEGBING trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; Chemical preparations for testing blood for medical purposes; Dietetic substances adapted for medical use; Biocides; first aid kits; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; Clinical medical reagents; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; Medicinal preparations for the mouth ...
pegbing

General Information


Serial Number97175380
Word MarkPEGBING
Filing DateThursday, December 16, 2021
Status700 - REGISTERED
Status DateTuesday, December 3, 2024
Registration Number7589159
Registration DateTuesday, December 3, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; Chemical preparations for testing blood for medical purposes; Dietetic substances adapted for medical use; Biocides; first aid kits; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; Clinical medical reagents; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; Medicinal preparations for the mouth and as sprays

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code005
First Use Anywhere DateWednesday, May 31, 2023
First Use In Commerce DateWednesday, May 31, 2023

Trademark Owner History


Party NameXIAMEN AMOYTOP BIOTECH CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressXiamen, Fujian 361022
CN

Party NameXIAMEN AMOYTOP BIOTECH CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressXiamen, Fujian 361022
CN

Party NameXIAMEN AMOYTOP BIOTECH CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressXiamen, Fujian 361022
CN

Trademark Events


Event DateEvent Description
Monday, December 20, 2021NEW APPLICATION ENTERED
Monday, December 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2022ASSIGNED TO EXAMINER
Thursday, April 21, 2022NON-FINAL ACTION WRITTEN
Thursday, April 21, 2022NON-FINAL ACTION E-MAILED
Thursday, April 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 12, 2022SOU EXTENSION 1 FILED
Monday, December 12, 2022SOU EXTENSION 1 GRANTED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 1, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 1, 2023SOU EXTENSION 2 FILED
Thursday, June 1, 2023SOU EXTENSION 2 GRANTED
Saturday, June 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 23, 2024USE AMENDMENT FILED
Tuesday, January 23, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, February 13, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 14, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, December 3, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED